Skip to main content
Clinical Trials/CTRI/2017/06/008755
CTRI/2017/06/008755CompletedPhase 2

Clinical Evaluation of PARANGIPATTAI CHOORANAM (Internal medicine) and ANNABEDHI CHENDURAM (External medicine) for VENPULLI (Vitiligo) in children

Self0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Self
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body.
  • 2.Patients who are willing to stay in IPD Ward for atleast 10 days or willing to attend OP Dept. as required.
  • 3.Patientâ??s informant / Parent willing to sign the informed consent stating that he/she will consciously stick to the treatment during 48 days but can opt out of the trial of his / her own conscious discretion.
  • 4.Willing to cooperate for taking photographs whenever required with hisher consent.

Exclusion Criteria

  • 1.Albinism
  • 2.Dermatological aspect of Leprosy
  • 3.Tinea versicolor
  • 4.Burn scars
  • 5.Dermatological aspect of Addisons diseases
  • 6.Post inflammatory hypopigmentation
  • 7.Pityriasis alba
  • 8.Alopecia aerate
  • 9.Chemical leucoderma

Investigators

Sponsor
Self

Similar Trials